Detailed information for compound 1555466

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 496.603 | Formula: C29H32N6O2
  • H donors: 0 H acceptors: 3 LogP: 4.68 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)C(c1nnnn1c1ccc(cc1)OC)N1CCN(CC1)C/C=C/c1ccccc1
  • InChi: 1S/C29H32N6O2/c1-36-26-14-10-24(11-15-26)28(29-30-31-32-35(29)25-12-16-27(37-2)17-13-25)34-21-19-33(20-22-34)18-6-9-23-7-4-3-5-8-23/h3-17,28H,18-22H2,1-2H3/b9-6+
  • InChiKey: OUIXOXRKYCGZIU-RMKNXTFCSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references
Homo sapiens ataxin 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Entamoeba histolytica hypothetical protein 0.0042 0.3762 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.003 0 0.5
Plasmodium vivax ataxin-2 like protein, putative 0.003 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0041 0.36 0.36
Leishmania major hypothetical protein, conserved 0.003 0 0.5
Loa Loa (eye worm) hypothetical protein 0.006 1 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 1 1
Entamoeba histolytica hypothetical protein 0.0042 0.3762 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0 0.5
Brugia malayi hypothetical protein 0.0042 0.3762 0.3762
Plasmodium falciparum ataxin-2 like protein, putative 0.003 0 0.5
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0042 0.3762 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0 0.5
Schistosoma mansoni transcription factor LCR-F1 0.0042 0.3762 1
Entamoeba histolytica hypothetical protein 0.0042 0.3762 0.5
Toxoplasma gondii LsmAD domain-containing protein 0.003 0 0.5
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 1 1
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.36 0.36
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0042 0.3762 0.5
Schistosoma mansoni hypothetical protein 0.0042 0.3762 1
Entamoeba histolytica hypothetical protein 0.0042 0.3762 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 11.2202 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 14.1254 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 29.0929 uM PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 35.4813 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.